Mono and dihydroxy coumarin derivatives: Copper chelation and reduction ability

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Pharmacology

Background:

• Limited availability of effective copper chelators drives research for new therapeutic agents.
• O-dihydroxycoumarins are known potent iron chelators under neutral conditions.
• Understanding copper interactions is crucial for various physiological and pathological processes.

Purpose of the Study:

• To evaluate the interaction of natural and synthetic coumarins with copper ions.
• To establish structure-activity relationships for coumarin-copper chelation across different pH conditions.
• To assess the copper-reducing properties of coumarin derivatives.

Main Methods:

• Utilized competitive and non-competitive assays to study copper chelation.
• Investigated coumarin interactions with cupric (Cu2+) and cuprous (Cu+) ions.
• Performed reduction experiments to quantify the copper-reducing potency of coumarins.

Main Results:

• O-dihydroxycoumarins demonstrated moderate cupric ion chelation, particularly under mildly competitive conditions.
• Cuprous ions were not chelated by the studied coumarins.
• Stoichiometry of chelation varied with pH and concentration, ranging from 1:1 to 2:1 for active compounds.
• 13 out of 15 coumarins reduced cupric ions, with o-dihydroxycoumarins being the most potent reducers.

Conclusions:

• O-dihydroxycoumarins exhibit moderate efficacy as cupric ion chelators.
• These compounds possess significant copper-reducing capabilities.
• The findings support further investigation of coumarins for copper-related therapeutic strategies.